Guardian Pharmacy Valuation
| GRDN Stock | 33.80 0.29 0.85% |
At this time, the firm appears to be fairly valued. Guardian Pharmacy retains a regular Real Value of USD33.67 per share. The prevalent price of the firm is USD33.8. Our model calculates the value of Guardian Pharmacy from evaluating the firm fundamentals such as return on asset of 0.11, and Return On Equity of 0.24 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Guardian Pharmacy's valuation include:
Price Book 11.7471 | Enterprise Value | Enterprise Value Ebitda 26.5493 | Price Sales 1.5534 | Forward PE 30.6748 |
Fairly Valued
Today
Please note that Guardian Pharmacy's price fluctuation is very steady at this time. Calculation of the real value of Guardian Pharmacy is based on 3 months time horizon. Increasing Guardian Pharmacy's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Guardian Pharmacy is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Guardian Stock. However, Guardian Pharmacy's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 33.8 | Real 33.67 | Target 35.0 | Hype 34.22 |
The intrinsic value of Guardian Pharmacy's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Guardian Pharmacy's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Guardian Pharmacy Services helps investors to forecast how Guardian stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Guardian Pharmacy more accurately as focusing exclusively on Guardian Pharmacy's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Guardian Pharmacy's intrinsic value based on its ongoing forecasts of Guardian Pharmacy's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Guardian Pharmacy's closest peers.
Guardian Pharmacy Cash |
|
Guardian Pharmacy Total Value Analysis
Guardian Pharmacy Services is currently forecasted to have valuation of 2.16 B with market capitalization of 2.16 B, debt of 37.33 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Guardian Pharmacy fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.16 B | 2.16 B | 37.33 M |
Guardian Pharmacy Investor Information
About 38.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. Based on the key measurements obtained from Guardian Pharmacy's financial statements, Guardian Pharmacy Services is not in a good financial situation at the moment. It has a very high risk of going through financial straits in March.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 61 M | 66.7 M |
|
|
Guardian Pharmacy Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Guardian Pharmacy has an asset utilization ratio of 382.91 percent. This suggests that the Company is making USD3.83 for each dollar of assets. An increasing asset utilization means that Guardian Pharmacy Services is more efficient with each dollar of assets it utilizes for everyday operations.Guardian Pharmacy Profitability Analysis
Based on the key profitability measurements obtained from Guardian Pharmacy's financial statements, Guardian Pharmacy Services may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in March. Profitability indicators assess Guardian Pharmacy's ability to earn profits and add value for shareholders.Net Loss | First Reported 2018-12-31 | Previous Quarter 9 M | Current Value 9.8 M | Quarterly Volatility 26 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.22 | 0.23 |
|
|
For Guardian Pharmacy profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Guardian Pharmacy to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Guardian Pharmacy utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Guardian Pharmacy's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Guardian Pharmacy over time as well as its relative position and ranking within its peers.
Guardian Pharmacy Earnings per Share Projection vs Actual
By analyzing Guardian Pharmacy's earnings estimates, investors can diagnose different trends across Guardian Pharmacy's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Guardian Pharmacy Services is based on EPS before non-recurring items and includes expenses related to employee stock options.Guardian Pharmacy Ownership Allocation
Guardian Pharmacy Services has a total of 36.25 Million outstanding shares. Over half of Guardian Pharmacy's outstanding shares are owned by outside corporations. These outside corporations are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Guardian Pharmacy Profitability Analysis
The company reported the previous year's revenue of 1.23 B. Net Loss for the year was (71.03 M) with profit before overhead, payroll, taxes, and interest of 274.32 M.About Guardian Pharmacy Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Guardian Pharmacy Services. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Guardian Pharmacy based exclusively on its fundamental and basic technical indicators. By analyzing Guardian Pharmacy's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Guardian Pharmacy's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Guardian Pharmacy. We calculate exposure to Guardian Pharmacy's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Guardian Pharmacy's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 281 M | 190.7 M | |
| Pretax Profit Margin | (0.06) | (0.06) | |
| Operating Profit Margin | (0.06) | (0.06) | |
| Net Loss | (0.08) | (0.08) | |
| Gross Profit Margin | 0.23 | 0.22 |
Guardian Pharmacy Quarterly Retained Earnings |
|
Guardian Pharmacy Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 62 M | |
| Forward Price Earnings | 30.6748 |
Guardian Pharmacy Current Valuation Indicators
Guardian Pharmacy's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Guardian Pharmacy's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Guardian Pharmacy, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Guardian Pharmacy's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Guardian Pharmacy's worth.When determining whether Guardian Pharmacy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Guardian Pharmacy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Guardian Pharmacy Services Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Guardian Pharmacy Services Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardian Pharmacy Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Will Consumer Staples Distribution & Retail sector continue expanding? Could Guardian diversify its offerings? Factors like these will boost the valuation of Guardian Pharmacy. Market participants price Guardian higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Guardian Pharmacy data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share 0.68 | Revenue Per Share | Quarterly Revenue Growth 0.2 | Return On Assets | Return On Equity |
Understanding Guardian Pharmacy requires distinguishing between market price and book value, where the latter reflects Guardian's accounting equity. The concept of intrinsic value - what Guardian Pharmacy's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Guardian Pharmacy's price substantially above or below its fundamental value.
Please note, there is a significant difference between Guardian Pharmacy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardian Pharmacy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Guardian Pharmacy's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.